Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Journal of Crohn'S & Colitis
|
May 10, 2026
Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's disease
Nurulamin M Noor, Haiyan Zheng, Zhi Cao, et al.
Plos One
|
February 18, 2009
Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease
Maureen J Koslowski, Irmgard Kübler, Mathias Chamaillard, et al.
Drugs in Context
|
February 7, 2025
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres
David Young, Sohail Rahmany, Deborah Taylor, et al.
BMJ Open
|
January 6, 2025
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial
Sarah Al-Shakhshir, Mohammed Nabil Quraishi, Benjamin Mullish, et al.
The Journal of the Royal College of Physicians of Edinburgh
|
June 16, 2021
Utility of Simulation via Instant Messaging - Birmingham Advance (SIMBA) in medical education during COVID-19 pandemic
Georgia Morgan, Eka Melson, Meri Davitadze, et al.
Gastrointestinal Endoscopy
|
March 18, 2018
The Paddington International Virtual Chromoendoscopy Score in ulcerative colitis exhibits very good inter-rater agreement after computerized module training: a multicenter study across academic and community practice (with video)
Palak J Trivedi, Ralf Kiesslich, James Hodson, et al.
Frontline Gastroenterology
|
September 3, 2020
Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic
Nicholas A Kennedy, Richard Hansen, Lisa Younge, et al.
Journal of Crohn'S & Colitis
|
December 14, 2024
Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic Signatures
Mohammed Nabil Quraishi, Jonathan Cheesbrough, Peter Rimmer, et al.
Gut
|
March 23, 2021
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
Nicholas A Kennedy, James R Goodhand, Claire Bewshea, et al.
Gut
|
June 10, 2020
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel
Shahida Din, Alexandra Kent, Richard C Pollok, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Journal of Crohn'S & Colitis
|
May 10, 2026
Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's disease
Nurulamin M Noor, Haiyan Zheng, Zhi Cao, et al.
Plos One
|
February 18, 2009
Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease
Maureen J Koslowski, Irmgard Kübler, Mathias Chamaillard, et al.
Drugs in Context
|
February 7, 2025
Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres
David Young, Sohail Rahmany, Deborah Taylor, et al.
BMJ Open
|
January 6, 2025
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial
Sarah Al-Shakhshir, Mohammed Nabil Quraishi, Benjamin Mullish, et al.
The Journal of the Royal College of Physicians of Edinburgh
|
June 16, 2021
Utility of Simulation via Instant Messaging - Birmingham Advance (SIMBA) in medical education during COVID-19 pandemic
Georgia Morgan, Eka Melson, Meri Davitadze, et al.
Gastrointestinal Endoscopy
|
March 18, 2018
The Paddington International Virtual Chromoendoscopy Score in ulcerative colitis exhibits very good inter-rater agreement after computerized module training: a multicenter study across academic and community practice (with video)
Palak J Trivedi, Ralf Kiesslich, James Hodson, et al.
Frontline Gastroenterology
|
September 3, 2020
Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic
Nicholas A Kennedy, Richard Hansen, Lisa Younge, et al.
Journal of Crohn'S & Colitis
|
December 14, 2024
Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic Signatures
Mohammed Nabil Quraishi, Jonathan Cheesbrough, Peter Rimmer, et al.
Gut
|
March 23, 2021
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
Nicholas A Kennedy, James R Goodhand, Claire Bewshea, et al.
Gut
|
June 10, 2020
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel
Shahida Din, Alexandra Kent, Richard C Pollok, et al.
Page
of 6